NutraIngredients-USA sat down with Aaron Secrist, executive vice president of Quality, Regulatory Affairs & Operations at NOW Health Group, to reflect on what has happened over the past year and what he thinks is next for the e-commerce giant.
From daily dietary microbe intake recommendations to emerging health endpoints like PCOS and weight management, and understanding the changing retail landscape, the exceptional content at the IPA World Congress + Probiota Americas Digital Summit continues...
Supplementation with a novel bacterium isolated from the human gut may counteract diet-induced obesity, insulin resistance, and inflammation, says a new study that creates “an incredible scientific opportunity”.
Biotech start-up FitBiomics has launched its first consumer product under the Nella brand, with more to come from the company that is mining the microbiomes of elite athletes for next generation probiotics.
A focus on transparency and direct benefits for the end user may help change the conversation around genetic engineering, says the CEO of the company behind the world’s first ever genetically engineered probiotic.
Supplementation with the human milk oligosaccharides (HMOs) HMOs 2'-fucosyllactose (2'FL), and lacto-N-neotetraose (LNnT) may normalize bowel function and improve bloating and IBS severity in adults, says a new study.
Powerful tools like artificial intelligence and CRISPR are set to drive next generation solutions to modulate the microbiome: Find out more at the upcoming IPA World Congress + Probiota Americas Digital Summit.
From the potential of artificial intelligence and CRISPR to modulate the microbiome to the science around probiotics and prebiotics and immune function and the changing retail landscape, the upcoming IPA World Congress + Probiota Americas is not to be...
Are you researching the latest state-of-the-art developments related to prebiotic, probiotic and microbiome science relevant to human health, well-being, consumers and industry? If so, we would like to hear from you!